WO2016059508A1 - A 3d porous cellulose scaffold for bone tissue engineering and the method for its preparation - Google Patents

A 3d porous cellulose scaffold for bone tissue engineering and the method for its preparation Download PDF

Info

Publication number
WO2016059508A1
WO2016059508A1 PCT/IB2015/057597 IB2015057597W WO2016059508A1 WO 2016059508 A1 WO2016059508 A1 WO 2016059508A1 IB 2015057597 W IB2015057597 W IB 2015057597W WO 2016059508 A1 WO2016059508 A1 WO 2016059508A1
Authority
WO
WIPO (PCT)
Prior art keywords
bone
cellulose
scaffold
particles
dimensional porous
Prior art date
Application number
PCT/IB2015/057597
Other languages
French (fr)
Inventor
Eugenijus LIESIS
Odeta BANIUKAITIENĖ
Alisa PALAVENIENĖ
Jolanta LIESIENĖ
Original Assignee
Uab "Biomė"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab "Biomė" filed Critical Uab "Biomė"
Publication of WO2016059508A1 publication Critical patent/WO2016059508A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608Bone, e.g. demineralised bone matrix [DBM], bone powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Definitions

  • the present invention relates to material engineering and could be applied in odontology or other kind of surgery for bone tissue regeneration in a defect site.
  • a 3D porous biocompatible cellulose scaffold which possesses biocompatibility, good osteoinductive and mechanical properties, is prepared as a composite comprising cellulose, as a natural polymer, and a biogenic source of calcium, such as particles of an autogenic (own), allogenic (of the same species, i.e. human, but of different person), or xenogenic (of other species) bone.
  • a structure of the composite, applicable for bone tissue regeneration, is formed by means of lyophilization or supercritical extraction of the samples presoaked with alcohol aqueous solutions.
  • the composites could be in block or granular forms and also a paste could be prepared.
  • Bone grafts used for bone tissue regeneration in odontology are as follows:
  • autogenic bone grafts i.e. an own bone of the patient from the other place.
  • allogenic bone grafts i.e. a bone of the same species (human), but of a different person. It fits by its physical properties, but there is a risk of disease transmission; - xenogenic bone grafts, i.e. a bone of other species, usually a bullock, after its deproteinization. The morphology does not fit to that of a human bone. Too quick resorption in the organism;
  • TCP tri calcium phosphate
  • HA hydroxyapatite
  • grafts are in powder or granule form (0.5-2 mm in size).
  • the main disadvantage is that they often conglomerate what hinder vascularization.
  • the resulted product is of insufficient strength and crumbles when screwing a metallic implant.
  • solid aggregates from bone-derived elements bonded to each other are prepared by means of different methods, e.g. agglutination, pressing, or caking.
  • Different bone particles, TCP, HA Wood J.M. et al. Implant, method of making same and use of the implant for the treatment of bone defects.
  • Patent No. US 6478825 Bl, 2002-11-02 or those minerals together with polymeric particles are used (Giorno T. PLGA/HA hydroxyapatite composite bone grafts and method of making. Pub. No. US 2013/02 18291 Al, 2013-08-22).
  • 3D composites are also obtained by means of electrospinning (Mei Wei, Fei Peng, Zhi-kang Xu. Electrospun apatite/polymer nano-composite scaffolds. Patent No. US7879093 B2, 2011-02-01) or using the rapid prototyping technology (Sawkins, M.J., et al. 3D Cell and scaffold patterning strategies in tissue engineering. Recent Patents on Biomedical Engineering, 2013, vol. 6, no. 1, p. 3-21; Teoh, S.H., et al. Three-dimensional bioresorbable scaffolds for tissue engineering applications. Patent No. US8071007 Bl, 2011-12-06).
  • Synthetic polymers such as poly(8-caprolactone), poly(L-lactic acid), poly(glycolic acid), poly(D,L-lactic-co-glycolic acid), polyphosphazenes, poly(propylene fumarate) are used (Muhammad, IS.; Xiaoxue, X.; Li, L. A review on biodegradable polymeric materials for bone tissue engineering applications. Journal of Materials Science, 2009, p. 5713— 5724).
  • poly(8-caprolactone) is most widely used (Dhandayuthapani, B., et al. Polymeric scaffolds in tissue engineering application: A review. International Journal of Polymer Science, 2011, vol. 2011, p. 1-19).
  • synthetic polymers are of lower biocompatibility than natural, they often cause necrosis of tissues, their degradation products, e.g. glycolic acid or other acidic compounds can increase local acidity and cause tissue lesions.
  • toxic metabolites in the organism can form during degradation of the polymers.
  • the methods described are complicated and do not give desirable porosity, because the particles are agglutinated or caked.
  • An important disadvantage is also the application of synthetic minerals TCP and HA as calcium raw materials.
  • the prototype of this invention is a cellulose-based three dimensional scaffold, with the surface mineralized in a simulated body fluid (SBF) (Petrauskaite, O. et.al. Biomimetic mineralization on a macroporous cellulose-based scaffold for bone regeneration. BioMed Research International. ISSN 2314-6133. 2013, vol. 2013, p. 1-9).
  • SBF simulated body fluid
  • a porous scaffold is formed by lyophilization of a regenerated cellulose gel.
  • the morphology of the porous scaffold obtained corresponds to that of a natural bone.
  • the substantial disadvantage of the scaffold is that cellulose is not bioactive, it does not ingrow with bone tissues, possesses very low osteoconductive properties.
  • the scaffold surface is mineralized in SBF.
  • synthetic minerals possess lower biocompatibility in comparison with natural ones.
  • the content of minerals in the composite reaches just up to 12 %, calculating from the cellulose weight.
  • the osteoconductive properties increase unremarkably.
  • the scaffold possesses poor mechanical properties (the Young's modulus is 4 MPa).
  • the aim of this invention is to prepare a porous three dimensional cellulose-based biocompatible scaffold of good osteoconductive and mechanical properties with the structure like that of a natural bone.
  • the present invention provides a composite comprising cellulose and biogenic bone particles at a ratio (w/w) 1 :0.12-6.0, wherein the diameter of the particles is 0.01-2000 microns.
  • a bone material which comprises inorganic compounds and polysaccharide chitin could be used as a biogenic bone.
  • the surface of the scaffold could be coated with collagen, platelet- rich fibrin, various growth factors, therapeutic additives, stem cells.
  • the three dimensional porous scaffold of the natural bone morphology is prepared by inserting biogenic bone particles into a cellulose gel during its formation from cellulose acetate at a ratio 1 :0.12- 6.0, afterwards loading the gel with an aqueous 10-30 % ethanol solution and freeze-dried or extracted with carbon dioxide at supercritical conditions at 24-70 MPa and 35-80°C temperature.
  • the resulting scaffold could be ground to granules of a desired size and/or the pasta could be prepared.
  • the advantages of the resulting scaffold are the following: natural components, such as cellulose and biogenic bone particles, are used.
  • Cellulose is biocompatible, not cytotoxic. Its degradation products are not toxic.
  • As a biogenic bone an autogenic, allogenic, or xenogenic (of any animal) bone could be used.
  • a milled bone material which comprises inorganic compounds and polysaccharide chitin could be used. It possesses antimicrobial and coagulation properties what give additional advantages.
  • the ratio (w/w) of cellulose to bone particles in the composite is equal to 1 : 0.12-6.0.
  • Fig. 1 Cross-section of the scaffold described in the 1st example, obtained by means of microcomputed tomography.
  • Fig. 3 Cross-section of the scaffold described in the 2nd example, obtained by means of microcomputed tomography.
  • Fig. 4 3D image of the scaffold described in the 2nd example, obtained by means of microcomputed tomography.
  • Ground bone particles are dispersed in the solution of cellulose acetate from which the gel with the particles is formed.
  • the particle size is in the range of 0.01-2000 microns, preferably up to 200 microns.
  • the porous structure which corresponds to the morphology of a natural bone is formed by lyophilization of the cellulose gel with the inserted bone particles loaded with the 10-30% alcoholic solution or by extraction with carbon dioxide at supercritical conditions at 24-70 MPa and 35-80°C temperature. Different water soluble alcohols could be used, preferably ethanol.
  • the resulting composites possess good mechanical properties, the Young's modulus is at least 8 MPa.
  • the morphology of the scaffolds corresponds to that of a natural bone (see Table).
  • the pore size is suitable for the vascularization and cell proliferation. The tests with mice showed that during two weeks a network of blood vessels was formed. The pores being interconnected are suitable for the nutrient and metabolite transport.
  • the osteocundutive characterization of the scaffolds was conducted with human osteoblastic cells MG-63 (ATCC® CRL-1427TM) (American Type Collection Culture, USA). The cells were seeded on the samples sterilized with UV rays for 24 h. The samples were soaked for 1 h in culture media, put to the 24 well plates (one sample in a plate) and covered with a suspension of the cells. The scaffolds with the cells were kept at 37°C in a 5% C0 2 atmosphere. Colonized materials were evaluated throughout the culture time by the DNA content after 1, 3, and 7 days using a fluorochrome Quant-iTTM PicoGreen® (Life Technologies, USA) according to the manufacturer's instructions.
  • the surface of the scaffolds could be coated with collagen, platelet-rich fibrin, various growth factors, therapeutic additives, stem cells.
  • the resulting scaffold could be in a block form easy shaped to an implant; could be ground to granules of a desired size; and/or a paste could be prepared.
  • the paste could be obtained by mixing the ground scaffold with glycerol, polyethylenglycol (molecular weight 400-600), or another hydrogel.
  • the Young's modulus of the resulting composite is 8 MPa.
  • the cross-section image obtained by means of microcomputed tomography is presented in Fig. 1, whereas 3D image in Fig. 2.
  • the results of cells proliferation on the graft are demonstrated in Fig. 5.
  • the Young's modulus of the resulting composite is 10 MPa.
  • the cross-section image obtained by means of microcomputed tomography is presented in Fig. 3, whereas 3D image in Fig. 4.
  • the results of cell proliferation on the graft are demonstrated in Fig. 5.
  • the Young's modulus of the resulting composite is 20 MPa.
  • the results of cell proliferation on the graft are demonstrated in Fig. 5.
  • the surface of resulting grafts is coated with collagen.
  • collagen of type 1 human, pig, rat, cow or recombinant
  • 0.1 M acetic acid according to Sigma Aldrich recommendations
  • the graft was put into a centrifuge vessel, covered with the collagen solution and centrifuged at 4000-6000 rpm min "1 for 10 minutes. After that the graft was freeze-dried.

Abstract

The present invention relates to material engineering and could be applied in odontology or other kind of surgery for bone tissue regeneration in a defect site. The aim of this invention is to prepare a porous three dimensional cellulose-based biocompatible scaffold of good osteoconductive and mechanical properties with the structure like that of a natural bone. To achieve the above object, the present invention provides a composite comprising cellulose and biogenic bone particles at a ratio (w/w) 1 :0.12-6.0, wherein the diameter of the particles is 0.01-2000 microns. In a separate case a bone material which comprises inorganic compounds and polysaccharide chitin could be used as a biogenic bone. In a separate case the surface of the scaffold could be coated with collagen, platelet- rich fibrin, various growth factors, therapeutic additives, stem cells. The three dimensional porous scaffold of the natural bone morphology is prepared by inserting biogenic bone particles into a cellulose gel during its formation from cellulose acetate at a ratio 1 :0.12- 6.0, afterwards loading the gel with an aqueous 10-30 % ethanol solution and freeze-dried or extracted with carbon dioxide at supercritical conditions at 24-70 MPa and 35-80°C temperature. The resulting scaffold could be ground to granules of a desired size and/or the pasta could be prepared.

Description

The present invention relates to material engineering and could be applied in odontology or other kind of surgery for bone tissue regeneration in a defect site.
A 3D porous biocompatible cellulose scaffold which possesses biocompatibility, good osteoinductive and mechanical properties, is prepared as a composite comprising cellulose, as a natural polymer, and a biogenic source of calcium, such as particles of an autogenic (own), allogenic (of the same species, i.e. human, but of different person), or xenogenic (of other species) bone. A structure of the composite, applicable for bone tissue regeneration, is formed by means of lyophilization or supercritical extraction of the samples presoaked with alcohol aqueous solutions. The composites could be in block or granular forms and also a paste could be prepared.
Bone grafts used for bone tissue regeneration in odontology are as follows:
autogenic bone grafts, i.e. an own bone of the patient from the other place.
Advantages: no immune response. Disadvantages: an additional operation is needed; lack of a bone; complicated shaping;
allogenic bone grafts, i.e. a bone of the same species (human), but of a different person. It fits by its physical properties, but there is a risk of disease transmission; - xenogenic bone grafts, i.e. a bone of other species, usually a bullock, after its deproteinization. The morphology does not fit to that of a human bone. Too quick resorption in the organism;
synthetic grafts. Among them the most popular are tri calcium phosphate (TCP) and hydroxyapatite (HA).
Most grafts are in powder or granule form (0.5-2 mm in size). The main disadvantage is that they often conglomerate what hinder vascularization. The resulted product is of insufficient strength and crumbles when screwing a metallic implant.
In order to get a porous 3D structure, solid aggregates from bone-derived elements bonded to each other are prepared by means of different methods, e.g. agglutination, pressing, or caking. Different bone particles, TCP, HA (Winterbottom J.M. et al. Implant, method of making same and use of the implant for the treatment of bone defects. Patent No. US 6478825 Bl, 2002-11-02), or those minerals together with polymeric particles are used (Giorno T. PLGA/HA hydroxyapatite composite bone grafts and method of making. Pub. No. US 2013/02 18291 Al, 2013-08-22). 3D composites are also obtained by means of electrospinning (Mei Wei, Fei Peng, Zhi-kang Xu. Electrospun apatite/polymer nano-composite scaffolds. Patent No. US7879093 B2, 2011-02-01) or using the rapid prototyping technology (Sawkins, M.J., et al. 3D Cell and scaffold patterning strategies in tissue engineering. Recent Patents on Biomedical Engineering, 2013, vol. 6, no. 1, p. 3-21; Teoh, S.H., et al. Three-dimensional bioresorbable scaffolds for tissue engineering applications. Patent No. US8071007 Bl, 2011-12-06). Synthetic polymers, such as poly(8-caprolactone), poly(L-lactic acid), poly(glycolic acid), poly(D,L-lactic-co-glycolic acid), polyphosphazenes, poly(propylene fumarate) are used (Muhammad, IS.; Xiaoxue, X.; Li, L. A review on biodegradable polymeric materials for bone tissue engineering applications. Journal of Materials Science, 2009, p. 5713— 5724). Among synthetic polymers poly(8-caprolactone) is most widely used (Dhandayuthapani, B., et al. Polymeric scaffolds in tissue engineering application: A review. International Journal of Polymer Science, 2011, vol. 2011, p. 1-19).
However, synthetic polymers are of lower biocompatibility than natural, they often cause necrosis of tissues, their degradation products, e.g. glycolic acid or other acidic compounds can increase local acidity and cause tissue lesions. Moreover, toxic metabolites in the organism can form during degradation of the polymers. The methods described are complicated and do not give desirable porosity, because the particles are agglutinated or caked. An important disadvantage is also the application of synthetic minerals TCP and HA as calcium raw materials.
The prototype of this invention is a cellulose-based three dimensional scaffold, with the surface mineralized in a simulated body fluid (SBF) (Petrauskaite, O. et.al. Biomimetic mineralization on a macroporous cellulose-based scaffold for bone regeneration. BioMed Research International. ISSN 2314-6133. 2013, vol. 2013, p. 1-9). In this case a porous scaffold is formed by lyophilization of a regenerated cellulose gel. The morphology of the porous scaffold obtained corresponds to that of a natural bone.
The substantial disadvantage of the scaffold is that cellulose is not bioactive, it does not ingrow with bone tissues, possesses very low osteoconductive properties. To enhance those properties the scaffold surface is mineralized in SBF. However synthetic minerals possess lower biocompatibility in comparison with natural ones. Moreover, while mineralized in SBF, just the surface of the scaffold is coated, therefore the content of minerals in the composite reaches just up to 12 %, calculating from the cellulose weight. Thus, the osteoconductive properties increase unremarkably. Moreover, the scaffold possesses poor mechanical properties (the Young's modulus is 4 MPa).
The aim of this invention is to prepare a porous three dimensional cellulose-based biocompatible scaffold of good osteoconductive and mechanical properties with the structure like that of a natural bone.
To achieve the above object, the present invention provides a composite comprising cellulose and biogenic bone particles at a ratio (w/w) 1 :0.12-6.0, wherein the diameter of the particles is 0.01-2000 microns. In a separate case a bone material which comprises inorganic compounds and polysaccharide chitin could be used as a biogenic bone. In a separate case the surface of the scaffold could be coated with collagen, platelet- rich fibrin, various growth factors, therapeutic additives, stem cells. The three dimensional porous scaffold of the natural bone morphology is prepared by inserting biogenic bone particles into a cellulose gel during its formation from cellulose acetate at a ratio 1 :0.12- 6.0, afterwards loading the gel with an aqueous 10-30 % ethanol solution and freeze-dried or extracted with carbon dioxide at supercritical conditions at 24-70 MPa and 35-80°C temperature. The resulting scaffold could be ground to granules of a desired size and/or the pasta could be prepared.
The advantages of the resulting scaffold are the following: natural components, such as cellulose and biogenic bone particles, are used. Cellulose is biocompatible, not cytotoxic. Its degradation products are not toxic. As a biogenic bone, an autogenic, allogenic, or xenogenic (of any animal) bone could be used. In a separate case a milled bone material which comprises inorganic compounds and polysaccharide chitin could be used. It possesses antimicrobial and coagulation properties what give additional advantages. The ratio (w/w) of cellulose to bone particles in the composite is equal to 1 : 0.12-6.0.
Brief description of the drawings.
Fig. 1 Cross-section of the scaffold described in the 1st example, obtained by means of microcomputed tomography.
Fig. 2 3D image of the scaffold described in the 1st example, obtained by means of microcomputed tomography. Fig. 3 Cross-section of the scaffold described in the 2nd example, obtained by means of microcomputed tomography.
Fig. 4 3D image of the scaffold described in the 2nd example, obtained by means of microcomputed tomography.
Fig. 5 Proliferation of cells on the scaffolds.
The method for preparing the scaffolds
Ground bone particles are dispersed in the solution of cellulose acetate from which the gel with the particles is formed. The particle size is in the range of 0.01-2000 microns, preferably up to 200 microns. The porous structure which corresponds to the morphology of a natural bone is formed by lyophilization of the cellulose gel with the inserted bone particles loaded with the 10-30% alcoholic solution or by extraction with carbon dioxide at supercritical conditions at 24-70 MPa and 35-80°C temperature. Different water soluble alcohols could be used, preferably ethanol. The resulting composites possess good mechanical properties, the Young's modulus is at least 8 MPa. The morphology of the scaffolds corresponds to that of a natural bone (see Table). The pore size is suitable for the vascularization and cell proliferation. The tests with mice showed that during two weeks a network of blood vessels was formed. The pores being interconnected are suitable for the nutrient and metabolite transport.
Table. The structural parameters of the resulting scaffolds and of a natural bone
Structural parameters
Bone grafts,
Mean
obtained Mean pore
Framework Specific framework
according the Porosity, % diameter, volume, % surface, mm 1 thickness,
examples mm mm
Example no. l 25 75 15 0.20 0.1-1.1
Example no.2 27 73 14 0.21 0.1-1.1
Example no.3 28 72 19 0.18 0.2-0.6
Jawbone (depends 7-49 72-93 9-30 0.12-0.41 0.4-1.7 on the site) The studies of human osteoblast MG-63 proliferation showed that obtained grafts possess better osteoconductive properties in comparison to the graft obtained according to the prototype (Fig. 5).
The method for the evaluation of osteocunductive properties.
The osteocundutive characterization of the scaffolds was conducted with human osteoblastic cells MG-63 (ATCC® CRL-1427™) (American Type Collection Culture, USA). The cells were seeded on the samples sterilized with UV rays for 24 h. The samples were soaked for 1 h in culture media, put to the 24 well plates (one sample in a plate) and covered with a suspension of the cells. The scaffolds with the cells were kept at 37°C in a 5% C02 atmosphere. Colonized materials were evaluated throughout the culture time by the DNA content after 1, 3, and 7 days using a fluorochrome Quant-iT™ PicoGreen® (Life Technologies, USA) according to the manufacturer's instructions.
The surface of the scaffolds could be coated with collagen, platelet-rich fibrin, various growth factors, therapeutic additives, stem cells. The resulting scaffold could be in a block form easy shaped to an implant; could be ground to granules of a desired size; and/or a paste could be prepared.
The paste could be obtained by mixing the ground scaffold with glycerol, polyethylenglycol (molecular weight 400-600), or another hydrogel.
1st example
To a solution of 25 g of cellulose acetate in 261 mL of an acetone-ammonia solution (v/v 1 :0.45) 15 g of an allogenic graft (the particle size less than 200 microns) is added. The resulting dispersion is poured into the vessels of a desired volume and shape and kept until a solid gel is formed. The gel is thoroughly washed with distilled water and afterwards is kept in an aqueous 25% ethanol solution for 24 hours and then freeze-dried.
The Young's modulus of the resulting composite is 8 MPa. The cross-section image obtained by means of microcomputed tomography is presented in Fig. 1, whereas 3D image in Fig. 2. The results of cells proliferation on the graft are demonstrated in Fig. 5. 2nd example
To a solution of 25 g of cellulose acetate in 267 mL of an acetone-ammonia solution (v/vl :0.5) 12 g of a ground cuttlebone (the particle size less than 100 microns) is added. The resulting dispersion is poured into the vessels of a desired volume and shape and kept until a solid gel is formed. The gel is thoroughly washed with distilled water and afterwards is kept in an aqueous 25% ethanol solution for 24 hours and then freeze-dried. Before using, proteins are washed out from the cuttlebone. For this the cuttlebone powder is kept in a 0.5 M sodium hydroxide solution for 5 hours at 80°C temperature. Afterwards the powder is thoroughly washed with distilled water, dried and sieved.
The Young's modulus of the resulting composite is 10 MPa. The cross-section image obtained by means of microcomputed tomography is presented in Fig. 3, whereas 3D image in Fig. 4. The results of cell proliferation on the graft are demonstrated in Fig. 5.
3rd example
To a solution of 10 g of cellulose acetate in 101.5 mL of an acetone-ammonia solution (v/v 1 :0.45) 12 g of a xenogenic bullock graft (the particle size less than 200 microns) is added. The resulting dispersion is poured into the vessels of desired volume and shape and kept until a solid gel is formed. The gel is thoroughly washed with distilled water and extracted with supercritical carbon dioxide at 30 MPa and 80 °C temperature.
The Young's modulus of the resulting composite is 20 MPa. The results of cell proliferation on the graft are demonstrated in Fig. 5.
4th example
The surface of resulting grafts is coated with collagen. For this purpose the collagen of type 1 (human, pig, rat, cow or recombinant) was dissolved in 0.1 M acetic acid according to Sigma Aldrich recommendations, diluted 10 times with a phosphate buffer and titrated with 0.1 M sodium hydroxide till pH 7. The graft was put into a centrifuge vessel, covered with the collagen solution and centrifuged at 4000-6000 rpm min"1 for 10 minutes. After that the graft was freeze-dried.

Claims

Claims
1. A three dimensional porous cellulose-based scaffold for bone tissue engineering possessing the morphology similar to a natural bone structure characterized in that it is composed of a cellulose composite with biogenic bone particles at the ratio (w/w) 1 : 0.12- 6.0, wherein the diameter of the particles is in the range of 0.01-2000 microns.
2. A three dimensional porous cellulose-based scaffold according to claim 1, wherein composed of cellulose with a bone material, which comprises inorganic compounds and polysaccharide chitin, 0.01-2000 micron particles.
3. A three dimensional porous cellulose-based scaffold according to claim 1 and 2, whereas its surface is coated with collagen, platelet-rich fibrin, various growth factors, therapeutic additives, stem cells.
4. A method for preparing a three dimensional porous scaffold based on regenerated cellulose characterized by the formation of a gel from a cellulose acetate solution with inserted particles of a biogenic bone at the ratio (w/w) 1 : 0.12-6.0.
5. A method for preparing a three dimensional porous scaffold by lyophilization of the regenerated cellulose gel obtained according to claim 4, wherein the cellulose gel with inserted biogenic bone particles is loaded with a 10-30 % alcoholic solution before its lyophilization.
6. A method for preparing a three dimensional porous scaffold, wherein the cellulose gel with inserted bone particles is loaded with a 10-30 % alcoholic solution and extracted with supercritical carbon dioxide at 24-70 MPa and 35-80 °C temperature.
7. A method for preparing a three dimensional porous scaffold, wherein the resulted block was ground to the desired particle size and/or the pasta was formed.
PCT/IB2015/057597 2014-10-13 2015-10-05 A 3d porous cellulose scaffold for bone tissue engineering and the method for its preparation WO2016059508A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LT2014117 2014-10-13
LT2014117A LT6309B (en) 2014-10-13 2014-10-13 Porous three dimensional cellulose based scaffold and method

Publications (1)

Publication Number Publication Date
WO2016059508A1 true WO2016059508A1 (en) 2016-04-21

Family

ID=54345553

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/057597 WO2016059508A1 (en) 2014-10-13 2015-10-05 A 3d porous cellulose scaffold for bone tissue engineering and the method for its preparation

Country Status (2)

Country Link
LT (1) LT6309B (en)
WO (1) WO2016059508A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2660588C1 (en) * 2017-07-18 2018-07-06 Федеральное государственное учреждение "Федеральный научно-исследовательский центр "Кристаллография и фотоника" Российской академии наук" Method of hydrogel hardening
CN114904052B (en) * 2022-05-06 2024-02-02 南京友德邦医疗科技有限公司 Novel degradable magnesium alloy vascular stent and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340477B1 (en) * 2000-04-27 2002-01-22 Lifenet Bone matrix composition and methods for making and using same
US6478825B1 (en) 2001-11-28 2002-11-12 Osteotech, Inc. Implant, method of making same and use of the implant for the treatment of bone defects
US7879093B2 (en) 2007-03-26 2011-02-01 University Of Connecticut Electrospun apatite/polymer nano-composite scaffolds
US8071007B1 (en) 2000-09-20 2011-12-06 Osteopore International Pte. Ltd. Three-dimensional bioresorbable scaffolds for tissue engineering applications
US20130218291A1 (en) 2012-02-21 2013-08-22 Thierry Giorno Plga/ha hydroxyapatite composite bone grafts and method of making

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340477B1 (en) * 2000-04-27 2002-01-22 Lifenet Bone matrix composition and methods for making and using same
US8071007B1 (en) 2000-09-20 2011-12-06 Osteopore International Pte. Ltd. Three-dimensional bioresorbable scaffolds for tissue engineering applications
US6478825B1 (en) 2001-11-28 2002-11-12 Osteotech, Inc. Implant, method of making same and use of the implant for the treatment of bone defects
US7879093B2 (en) 2007-03-26 2011-02-01 University Of Connecticut Electrospun apatite/polymer nano-composite scaffolds
US20130218291A1 (en) 2012-02-21 2013-08-22 Thierry Giorno Plga/ha hydroxyapatite composite bone grafts and method of making

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DHANDAYUTHAPANI, B. ET AL.: "Polymeric scaffolds in tissue engineering application: A review", INTERNATIONAL JOURNAL OFPOLYMER SCIENCE, vol. 2011, 2011, pages 1 - 19
MUHAMMAD, I.S.; XIAOXUE, X.; LI, L.: "A review on biodegradable polymeric materials for bone tissue engineering applications", JOURNAL OF MATERIALS SCIENCE, 2009, pages 5713 - 5724
ODETA PETRAUSKAITE ET AL: "Biomimetic Mineralization on a Macroporous Cellulose-Based Matrix for Bone Regeneration", BIOMED RESEARCH INTERNATIONAL, vol. 2013, 1 January 2013 (2013-01-01), US, pages 1 - 9, XP055235063, ISSN: 2314-6133, DOI: 10.1155/2013/452750 *
PETRAUSKAITE, O.: "Biomimetic mineralization on a macroporous cellulose-based scaffold for bone regeneration", BIOMED RESEARCH INTERNATIONAL., vol. 2013, 2013, pages 1 - 9
SAWKINS, M.J. ET AL.: "3D Cell and scaffold patterning strategies in tissue engineering", RECENT PATENTS ON BIOMEDICAL ENGINEERING, vol. 6, no. 1, 2013, pages 3 - 21

Also Published As

Publication number Publication date
LT2014117A (en) 2016-05-10
LT6309B (en) 2016-08-25

Similar Documents

Publication Publication Date Title
Levengood et al. Chitosan-based scaffolds for bone tissue engineering
Taghipour et al. The application of hydrogels based on natural polymers for tissue engineering
Eldeeb et al. Biomaterials for tissue engineering applications and current updates in the field: A comprehensive review
CN101301491B (en) Composite bracket made of multialdehyde sodium alginate crosslinked calcium polyphosphate/chitosan and preparation and use thereof
US20090022770A1 (en) Chitosan Compositions
Hadavi et al. Novel calcified gum Arabic porous nano-composite scaffold for bone tissue regeneration
US20070254007A1 (en) Chitosan/nanocrystalline hydroxyapatite composite microsphere-based scaffolds
CA2532829A1 (en) High density fibrous polymers suitable for implant
Ariani et al. New development of carbonate apatite-chitosan scaffold based on lyophilization technique for bone tissue engineering
Manoukian et al. Spiral layer-by-layer micro-nanostructured scaffolds for bone tissue engineering
KR20130037324A (en) Composition and method for 3d printing stacking of scaffold adequate to multi-material for bone regenerating
CN103007358B (en) Cartilage tissue engineering fiber scaffold material and preparation method thereof
Goh et al. Fabrication and in vitro biocompatibility of sodium tripolyphosphate-crosslinked chitosan–hydroxyapatite scaffolds for bone regeneration
CN102085392B (en) Nano-apatite/collagen compound stent and preparation method and application thereof
Stępniewski et al. Chitosan and its composites: Properties for use in bone substitution
Kumbhar et al. Self-functionalized, oppositely charged chitosan-alginate scaffolds for biomedical applications
Yuvarani et al. Chitosan modified alginate-polyurethane scaffold for skeletal muscle tissue engineering
Vu et al. Fabrication of in situ crosslinking hydrogels based on oxidized alginate/N, O-carboxymethyl chitosan/β-tricalcium phosphate for bone regeneration
WO2016059508A1 (en) A 3d porous cellulose scaffold for bone tissue engineering and the method for its preparation
KR101379894B1 (en) Bone graft materials using transgenic pig bone, method of preparing the same, and ceramic materials for biomedical application comprising the same, and
He et al. Synergistic effect of mesoporous silica and hydroxyapatite in loaded poly (DL-lactic-co-glycolic acid) microspheres on the regeneration of bone defects
RU2554804C1 (en) Method for preparing calcium phosphate composite
CN114681668B (en) Preparation method of 3D printed selenium-doped hydroxyapatite artificial bone structure
Sudha et al. Perspectives of chitin-and chitosan-based scaffolds dressing in regenerative medicine
WO2019077348A1 (en) Porous material

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15784478

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15784478

Country of ref document: EP

Kind code of ref document: A1